Maintenance of muscle mass is not dependent on the calcineurin-NFAT pathway

In this study, the role of the calcineurinpathway in skeletal muscle atrophy and atrophy-reducing interventionswas investigated in rat soleus muscles. Because calcineurin has beensuggested to be involved in skeletal and cardiac muscle hypertrophy, we hypothesized that blocking calcineurin activity would eliminate beneficial effects of interventions that maintain muscle mass in theface of atrophy-inducing stimuli. Hindlimb suspension and spinal cordtransection were used to induce atrophy, and intermittent reloading andexercise were used to reduce atrophy. Cyclosporin (CsA, 25 mg · kg¹ · day¹) wasadministered to block calcineurin activity. Soleus muscles were studied14 days after the onset of atrophy. CsA administration did not inhibitthe beneficial effects of the two muscle-maintaining interventions, nordid it change muscle mass in control or atrophied muscles, suggestingthat calcineurin does not play a role in regulating muscle size duringatrophy. However, calcineurin abundance was increased in atrophiedsoleus muscles, and this was associated with nuclear localization ofNFATc1 (a nuclear factor of activated T cells). Therefore, resultssuggest that calcineurin may be playing opposing roles during skeletalmuscle atrophy and under muscle mass-maintaining conditions.